Urticaria Control Test News Today

Urticaria severity reduced within weeks of treatment

- Phase 2 CSU enrollment complete; topline data by YE 2023 -

The UCT7 reduces the Urticaria Control Test’s 4-week recall period to 7 days to assess disease control at short intervals in clinical studies and practice, according to a study published in The Journal of Allergy and Clinical Immunology.Researchers validated the UCT7 against results from a variety of other patient-reported outcome measures and tools, Thomas Buttgereit, MD, of the Institute

08.08.2022 - - Positive interim data from barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria presented at EAACI 2022 - - First patients dosed in Phase 2 chronic urticaria studies - HAMPTON, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) - Celldex ...

- Rapid and sustained improvement in urticaria control after single dose of CDX-0159 -- Greatly improved patient quality of life and reduced disease impact...